Search

everythinglearnresearchcommunity

for

Search:↓

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

People with alopecia areata have a higher risk of heart disease.

Uveodermatological syndrome in dogs is hard to manage and can lead to blindness despite treatment.

Therapy lowers IgM levels in dogs with severe dermatitis but not in mild cases.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

Cyclosporin doesn't stop hair loss.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Indian jujube has many medicinal properties and can help treat ailments like diabetes, inflammation, and cancer.

Microneedling, especially with halometasone, improves hair regrowth and gut health in alopecia areata.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Certain gene changes in osteopontin are linked to higher risk of atopic dermatitis and asthma.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Vitamin D deficiency is common in children with and without alopecia areata, and more research is needed.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Prurigo nodularis is hard to diagnose and treat, but new biologics offer hope for better management.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

AD-derived keratinocytes effectively mimic inflammation in atopic dermatitis.

Probiotics may help treat skin conditions like acne and eczema safely.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.